
2.63 Delayed Data As of Mar 27 | ![]() Today’s Change | 2.54 Today|||52-Week Range 9.75 | -17.30% Year-to-Date |
Aeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimates Mar 23 / Zacks.com - Paid Partner Content |
Previous close | 2.63 |
Today’s open | 2.63 |
Day’s range | 2.63 - 2.63 |
Volume | 100 |
Average volume (3 months) | 15,217 |
Market cap | $12.8M |
Earnings growth (last year) | -157.13% |
Earnings growth (this year) | +29.49% |
Earnings growth (next 5 years) | +1.00% |
Revenue growth (last year) | +7.22% |
P/E ratio | NM |
Price/Sales | 2.73 |
Price/Book | 0.36 |
Today’s change | Today’s % change | |
---|---|---|
CLXTCalyxt Inc | +0.00 | +0.91% |
HTGMHTG Molecular Diagno... | +0.14 | +3.94% |
OPGNOpGen Inc | +0.02 | +1.40% |
SASISigma Additive Solut... | -0.01 | -2.31% |
Next reporting date | May 10, 2023 |
EPS forecast (this quarter) | -$0.93 |
Annual revenue (last year) | $5.6M |
Annual profit (last year) | -$22.7M |
Net profit margin | -402.96% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Toronto, Ontario |